Key Figures

Operating incomeEUR 4.8billion
53,155employees worldwide
EUR 5.0billion expenditure in Research and
Development
Human PharmaEUR 18.5billion
thereof10,691in Research, Development and Medicine
equivalent to20.9%of total net sales
Animal HealthEUR 4.6billion
Biopharmaceutical
Contract Manufacturing
EUR 1.0billion

Key figure calculator

Key Figures
Export
View
  • Net Sales

  • Human Pharma

  • Animal Health

  • Biopharmaceutical Contract Manufacturing

  • Other Sales

202020212022
Net Salesin € million19.56620.61824.149
Human Pharmain € million14.41515.29418.461
Animal Healthin € million4.1214.2954.559
Biopharmaceutical Contract Manufacturingin € million8379171.024
Other Salesin € million33112105
Year
Key Figures
Export
View
  • Operating income

202020212022
Operating incomein € million4.6244.7054.770
Year
Key Figures
Export
View
  • Investments into R&D

  • - as % of net sales

202020212022
Investments into R&Din € million3.6964.1275.047
- as % of net salesin %18,92020,9
Year
Download the Financial Report